Novel,highly potent,selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics |
| |
| Authors: | Lee Taekyu Robichaud Albert J Boyle Kristopher E Lu Yimin Robertson David W Miller Keith J Fitzgerald Larry W McElroy John F Largent Brian L |
| |
| Affiliation: | Discovery Chemistry, Bristol-Myers Squibb Company, Wilmington, DE 19880, USA. taekyu.lee@bms.com |
| |
| Abstract: | 
The discovery of N-substituted-pyridoindolines and their binding affinities at the 5-HT(2A), 5-HT(2C) and D(2) receptors, and in vivo efficacy as 5-HT(2A) antagonists is described. The structure-activity relationship of a series of core tetracyclic derivatives with varying butyrophenone sidechains is also discussed. This study has led to the identification of potent, orally bioavailable 5-HT(2A)/D(2) receptor dual antagonists as potential atypical antipsychotics. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
|
